Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Jia, Chenglin ^a   Xiong, Minqi ^a   Wang, Peiwei ^a   Cui, Jingang ^a   Du, Xiaoye ^a   Yang, Qinbo ^a   Wang, Wenjian ^a,b   Chen, Yu ^a   Zhang, Teng ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CARDIOVASCULAR AGENT; CHOLESTEROL; GAMMA INTERFERON; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MALATE DEHYDROGENASE; MICRORNA; MICRORNA 126; MICRORNA 126A; MICRORNA 132; MICRORNA 146; MICRORNA 155; MICRORNA 20A; MICRORNA 21; MICRORNA 26A; MICRORNA 92A; NOTOGINSENOSIDE R1; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; GINSENOSIDE; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; FIBROSIS; GENE EXPRESSION; LIPID STORAGE; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; PROTEIN FUNCTION; ANIMAL; AORTA; BLOOD; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIPID METABOLISM; METABOLISM; PATHOLOGY;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GINSENOSIDES; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIPIDS; MICE, INBRED C57BL; MICRORNAS; OXIDATIVE STRESS;

EID: 84903135425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099849     Document Type: Article

References (35)

1. Lusis AJ (2000) Atherosclerosis. Nature 407: 233-241.
2. Toth PP (2003) Reverse cholesterol transport: high-density lipoprotein's magnificent mile. Curr Atheroscler Rep 5: 386-393.
3. Toth PP (2004) High-Density Lipoprotein and Cardiovascular Risk. Circulation 109: 1809-1812.
4. Mahdy Ali K, Wonnerth A, Huber K, Wojta J (2012) Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities. Br J Pharmacol 167: 1177-1194.
5. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
6. Hansson GK, Robertson AK, Soderberg-Naucler C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
7. Manduteanu I, Simionescu M (2012) Inflammation in atherosclerosis: a cause or a result of vascular disorders? J Cell Mol Med 16: 1978-1990.
8. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative Stress and Vascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 29-38. (Pubitemid 40054251)
9. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. (Pubitemid 38868508)
10. Hulsmans M, De Keyzer D, Holvoet P (2011) MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. Faseb J 25: 2515-2527.
11. Zampetaki A, Dudek K, Mayr M (2013) Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling. Free Radic Biol Med 64: 69-77.
12. O'Connell RM, Rao DS, Baltimore D (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30: 295-312.
13. Ling S, Nheu L, Dai A, Guo Z, Komesaroff P (2008) Effects of four medicinal herbs on human vascular endothelial cells in culture. Int J Cardiol 128: 350-358.
14. Dou L, Lu Y, Shen T, Huang X, Man Y, et al. (2012) Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice. Cell Physiol Biochem 29: 875-882.
15. Wan JB, Lee SM, Wang JD, Wang N, He CW, et al. (2009) Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. J Agric Food Chem 57: 6692-6697.
16. Sun B, Xiao J, Sun XB, Wu Y (2013) Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling. Br J Pharmacol 168: 1758-1770.
17. Liu WJ, Tang HT, Jia YT, Ma B, Fu JF, et al. (2010) Notoginsenoside R1 attenuates renal ischemia-reperfusion injury in rats. Shock 34: 314-320.
18. Li C, Li Q, Liu YY, Wang MX, Pan CS, et al. (2014) Protective effects of Notoginsenoside R1 on intestinal ischemia-reperfusion injury in rats. Am J Physiol Gastrointest Liver Physiol 306: G111-122.
19. Zhang WJ, Wojta J, Binder BR (1997) Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo. Arterioscler Thromb Vasc Biol 17: 465-474. (Pubitemid 27133135)
20. Tamminen M, Mottino G, Qiao JH, Breslow JL, Frank JS (1999) Ultrastructure of early lipid accumulation in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19: 847-853. (Pubitemid 29177328)
21. Ji W, Gong BQ (2007) Hypolipidemic effects and mechanisms of Panax notoginseng on lipid profile in hyperlipidemic rats. J Ethnopharmacol 113: 318-324. (Pubitemid 47239259)
22. Meng X, Wang M, Wang X, Sun G, Ye J, et al. (2014) Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways. Free Radic Res 7: 7.
23. Meng X, Sun G, Ye J, Xu H, Wang H, et al. (2014) Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: a novel mechanism of Nrf2/ARE signaling activation. Free Radic Res 48: 445-460.
24. Nakamura Y, Suzuki T, Miki Y, Tazawa C, Senzaki K, et al. (2004) Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens. Mol Cell Endocrinol 219: 17-26. (Pubitemid 38659521)
25. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43: 985-991. (Pubitemid 29413198)
26. Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, et al. (2010) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24: 460-466.
27. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, et al. (2007) MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9: 775-787. (Pubitemid 47019464)
28. Zheng L, Xu CC, Chen WD, Shen WL, Ruan CC, et al. (2010) MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts. Biochem Biophys Res Commun 400: 483-488.
29. Chen T, Huang Z, Wang L, Wang Y, Wu F, et al. (2009) MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 83: 131-139.
30. Fleissner F, Jazbutyte V, Fiedler J, Gupta SK, Yin X, et al. (2010) Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21- dependent mechanism. Circ Res 107: 138-143.
31. Ji R, Cheng Y, Yue J, Yang J, Liu X, et al. (2007) MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588. (Pubitemid 46897261)
32. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, et al. (2011) MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 226: 1035-1043.
33. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101: 59-68. (Pubitemid 47094624)
34. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, et al. (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16: 909-914.
35. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, et al. (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.